Cullinan Therapeutics backed Boston’s OUTbio networking event through its PRISM initiative, signaling continued support for LGBTQIA talent and inclusion in biot

Cullinan Therapeutics backed Boston’s OUTbio networking event through its PRISM initiative, signaling continued support for LGBTQIA talent and inclusion in biotech. The sponsorship comes as the company advances CLN-049 toward Phase 2 in AML.